Cortechs.ai | Poster – Performance Evaluation for Automated Lesion Segmentation Tool: LesionQuant

Poster – Performance Evaluation for Automated Lesion Segmentation Tool: LesionQuant

Cortechs.ai was pleased to present this poster at AAN in Boston – April 2017.

Quantitative measures such as lesion volume and distribution have significant value for clinicians evaluating disease progression. Clinical standards for lesion evaluation include visual inspection of MRI images, or expert manual segmentation of lesions. These subjective measurements are often vulnerable to inter- and intra-rater variability, resulting in low reproducibility.

Cortechs.ai’ LesionQuant is a fully-automated lesion segmentation tool for clinical use designed to provide accurate and reproducible lesion segmentations. This study objectively demonstrates that the accuracy of LesionQuant is comparable to expert manual segmentation of lesions and had high reproducibility, making it a useful tool in the quantitative analysis of the brain lesions.

For more information about LesionQuant or this poster, contact us. Click image below to view in pdf.

Cortechs.ai | Poster – Performance Evaluation for Automated Lesion Segmentation Tool: LesionQuant

More Resources

10/15/2025

Sharper Screening, Smarter Biopsies: OnQ Prostate and the Next Step in Imaging

Read to learn how OnQ Prostate goes beyond existing solutions like DynaCAD and redefines biopsy precision

10/14/2025

Cortechs.ai Acquires ZepMed to Expand AI-Powered Neuroimaging Capabilities

This strategic acquisition strengthens Cortechs.ai’s position at the forefront of radiological innovation and expands its suite of best-in-class solutions

10/07/2025

Cortechs.ai Expands Partnership with Strategic Radiology to Advance Imaging Innovation Across Private Practices

Cortechs.ai and Strategic Radiology have now broadened their alliance to include Cortechs.ai’s full suite of imaging solutions.

10/06/2025

Clinical Performance of NeuroQuant: Transforming Brain MRI Analysis

NeuroQuant has consistently demonstrated strong clinical performance across multiple conditions, including Alzheimer’s , epilepsy, TBI, and MS.

10/02/2025

WEBINAR: Navigating Category III CPT Codes for Quantitative Imaging

Leveraging Compatible CPT Codes for NeuroQuant and OnQ Prostate

09/29/2025

The Role of NeuroQuant in Supporting Alzheimer’s Disease Care

NeuroQuant equips clinicians and researchers with data that can support earlier recognition of disease, track progression, and evaluate treatment efficacy.
Scroll to Top